Research Facility
Cleveland, Ohio 44195
We've found
1 trials
at this facility
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials